GI-6207 (Saccharomyces cerevisiae-based immunotherapy targeting CEA)

Pharmaceuticals

Research studies on GI-6207 (Saccharomyces cerevisiae-based immunotherapy targeting CEA) - conditions it treats, mechanisms of action, and clinical outcomes from peer-reviewed literature.

Loading research data...

Explore The Full Database

Related Terms

GI-6207 (Saccharomyces cerevisiae-based immunotherapy targeting CEA)